Current Ratio in % of Marker Therapeutics, Inc. from Q1 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Marker Therapeutics, Inc. quarterly Current Ratio history and change rate from Q1 2012 to Q3 2025.
  • Marker Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 556 %, a 11.7% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Marker Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 556 +58.1 +11.7% 30 Sep 2025
Q2 2025 472 -144 -23.3% 30 Jun 2025
Q1 2025 540 -115 -17.6% 31 Mar 2025
Q4 2024 524 +27 +5.44% 31 Dec 2024
Q3 2024 498 +129 +34.8% 30 Sep 2024
Q2 2024 616 +351 +133% 30 Jun 2024
Q1 2024 656 +446 +212% 31 Mar 2024
Q4 2023 497 +253 +104% 31 Dec 2023
Q3 2023 369 +88.6 +31.6% 30 Sep 2023
Q2 2023 264 -104 -28.2% 30 Jun 2023
Q1 2023 210 -328 -61% 31 Mar 2023
Q4 2022 244 -483 -66.5% 31 Dec 2022
Q3 2022 281 -552 -66.3% 30 Sep 2022
Q2 2022 368 -451 -55.1% 30 Jun 2022
Q1 2022 538 -190 -26.1% 31 Mar 2022
Q4 2021 727 +87.9 +13.7% 31 Dec 2021
Q3 2021 832 -112 -11.8% 30 Sep 2021
Q2 2021 820 -476 -36.7% 30 Jun 2021
Q1 2021 728 -934 -56.2% 31 Mar 2021
Q4 2020 639 -1.2K -65.2% 31 Dec 2020
Q3 2020 944 -906 -49% 30 Sep 2020
Q2 2020 1.3K -115 -8.13% 30 Jun 2020
Q1 2020 1.66K +659 +65.7% 31 Mar 2020
Q4 2019 1.84K +1.22K +199% 31 Dec 2019
Q3 2019 1.85K +1.67K +923% 30 Sep 2019
Q2 2019 1.41K +1.16K +456% 30 Jun 2019
Q1 2019 1K +641 +177% 31 Mar 2019
Q4 2018 614 +188 +44.1% 31 Dec 2018
Q3 2018 181 -272 -60.1% 30 Sep 2018
Q2 2018 254 30 Jun 2018
Q1 2018 361 31 Mar 2018
Q4 2017 426 31 Dec 2017
Q3 2017 452 30 Sep 2017
Q2 2016 19.3 30 Jun 2016
Q1 2016 13.3 31 Mar 2016
Q1 2013 1.83 -3.08 -62.7% 31 Mar 2013
Q4 2012 1.29 31 Dec 2012
Q3 2012 3.1 30 Sep 2012
Q2 2012 3.91 30 Jun 2012
Q1 2012 4.91 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.